StonvexLoading…
StonvexStonvexStonvexCore line items from PGY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $298.99M | $1.26B | $940.30M | $600.42M |
Operating Income | $80.00M | $263.83M | $184.11M | $104.15M |
Net Income | $24.69M | $81.39M | $47.09M | $24.55M |
EPS (Diluted) | $0.28 | $0.93 | $0.55 | $0.29 |
Total Assets | $1.65B | $1.55B | $1.46B | $1.40B |
Total Liabilities | $1.02B | $960.46M | $889.44M | $856.81M |
Cash & Equivalents | $317.81M | $235.33M | $218.31M | $182.99M |
Free Cash Flow OCF − CapEx | $40.01M | $224.72M | $148.01M | $84.20M |
Shares Outstanding | 96.75M | 83.10M | 80.95M | 78.30M |